Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Journal Article

Comparative effectiveness research (CER) aims to provide decision makers with the evidence needed to evaluate the benefits and harms of alternative clinical management strategies. CER has become a national priority, with considerable new research funding allocated. Cardiovascular disease is a priority area for CER. This workshop report provides an overview of CER methods, with an emphasis on practical clinical trials and observational treatment comparisons. The report also details recommendations to the National Heart, Lung, and Blood Institute for a new framework for evidence development to foster cardiovascular CER, and specific studies to address 8 clinical issues identified by the Institute of Medicine as high priorities for cardiovascular CER.

Full Text

Duke Authors

Cited Authors

  • Hlatky, MA; Douglas, PS; Cook, NL; Wells, B; Benjamin, EJ; Dickersin, K; Goff, DC; Hirsch, AT; Hylek, EM; Peterson, ED; Roger, VL; Selby, JV; Udelson, JE; Lauer, MS

Published Date

  • August 14, 2012

Published In

Volume / Issue

  • 60 / 7

Start / End Page

  • 569 - 580

PubMed ID

  • 22796257

Pubmed Central ID

  • PMC3416944

Electronic International Standard Serial Number (EISSN)

  • 1558-3597

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2011.12.057


  • eng

Conference Location

  • United States